Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice

Experimental Neurology

Volumn 158, Issue 1, 1999, Pages 234-241

  Montine, Thomas J ^a   Montine, Kathleen S ^a   Olson, Sandra J ^a   Graham, Doyle G ^a   Roberts II, L Jackson ^a   Morrow, Jason D ^a   Linton, MacRae F ^a   Fazio, Sergio ^a   Swift, Larry L ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; FATTY ACID; PHOSPHOLIPID; SYNAPTOPHYSIN;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; FEMALE; HOMOZYGOSITY; LIPID PEROXIDATION; MALE; MOUSE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL;

EID: 0032839939     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7067     Document Type: Article

References (54)

1. Roses A. D. Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer's disease. Neurobiol. Aging. 15:1994;S165-S167.
2. Jordan B. D., Relkin N. R., Ravdin L. D., Jacobs A. R., Bennett A., Gandy S. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. J. Am. Med. Assoc. 278:1997;136-140.
3. Strittmatter W. J., Roses A. D. Apolipoprotein E and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 92:1995;4725-4727.
4. Strittmatter W. J., Weisgraber K. H., Goedert M. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125:1994;163-171.
5. Corder E. H., Saunders A. M., Strittmatter W. J. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
6. Nathan B., Chang K., Bellosta S. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270:1995;19791-19799.
7. Bellosta S., Nathan B., Orth M., Dong L., Mahley R., Pitas R. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270:1995;27063-27071.
8. Fagan A., Bu G., Sun Y., Daugherty A., Holtzman D. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271:1996;30121-30125.
9. Gutman C. R., Strittmatter W. J., Weisgraber K. H., Matthew W. D. Apolipoprotein E binds and potentiates the biological activity of ciliary neurotrophic factor. J. Neurosci. 17:1997;6114-6121.
10. Holtzman D., Pitas R., Kilbridge J. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA. 92:1995;9480-9484.
11. Huang D., Weisgraber K., Strittmatter W., Matthew W. Interaction of apolipoprotein E with laminin increases neuronal adhesion and alters neurite morphology. Exp. Neurol. 136:1995;251-257.
12. Mahley R., Nathan B., Bellosta S., Pitas R. Apolipoprotein E: Impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease. Curr. Opin. Lipidol. 6:1995;86-91.
13. Pitas R. E., Ji Z. S., Weisgraber K. H., Mahley R. W. Role of apolipoprotein E in modulating neurite outgrowth: Potential effect of intracelular apolipoprotein E. Biochem. Soc. Trans. 26:1998;257-262.
14. Sun Y. L., Wu S., Bu G. J. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice - Astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J. Neurosci. 18:1998;3261-3272.
15. Miyata M., Smith J. D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14:1996;55-61.
16. Mahley R. W., Innerarity T. L., Rall S. C., Weisgraber K. H. Plasma lipoproteins: Apolipoprotein structure and function. J. Lipid Res. 25:1984;1277-1294.
17. Matthews R., Beal M. Increased 3-nitrotyrosine in brains of apoE-deficient mice. Brain Res. 718:1996;181-184.
18. DeSarno P., Jope R. S. Phosphoinositide hydrolysis activated by muscarinic or glutaminergic, but not adrenergic, receptor is impaired in apoE-deficient mice and by hydrogen peroxide and peroxynitite. Exp. Neurol. 152:1998;123-128.
19. Chen Y., Lommnitski L., Michaelson D. M., Shohami E. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience. 80:1997;1255-1262.
20. Chapman S., Michaelson D. M. Specific neurochemical derangements of brain projecting neurons on apolipoprotein E-deficient mice. J. Neurochem. 70:1998;708-714.
21. Genis I., Gordon I., Sehayek E., Michaelson D. M. Phosphorylation of tau on apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;5-8.
22. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D. M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
23. Gordon I., Genis I., Grauer E., Sehayek E., Michaelson D. M. Biochemical and cognitive studies of apolipoprotein-E-deficient mice. Mol. Chem. Neuropathol. 28:1996;97-103.
24. Oitzl M. S., Mulder M., Lucassen P. J., Havekes L. M., Grootendorst J., deKloet E. R. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res. 752:1997;189-196.
25. Anderson R., Higins G. A. Absence of central cholinergic deficits in apoE knockout mice. Psychopharmacology. 132:1997;135-144.
26. Anderson R., Barnes J. C., Bliss T. V. Behavioural, physiological, and morphological analysis of a line of apolipoproteins E knockout mouse. Neuroscience. 85:1998;93-110.
27. Fagan A., Murphy B. A., Patel S. N. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury. Exp. Neurol. 151:1998;314-325.
28. Raber J., Wong D., Buttini M. Isoform-specific effects of human apolipoprotein E on brain function revealed in apoE knockout mice: Increased susceptibility of females. Proc. Natl. Acad. Sci. USA. 95:1998;10914-10919.
29. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A. D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136:1995;107-122.
30. Mahley R. W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
31. Montine K., Olson S., Amarnath V., Whetsell W., Graham D., Montine T. Immunochemical detection of 4-hydroxynonenal adducts in Alzheimer's disease is associated with APOE4. Am. J. Pathol. 150:1997;437-443.
32. Montine K. S., Kim P. J., Olson S. J., Markesbery W. R., Montine T. J. 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J. Neuropathol. Exp. Neurol. 56:1997;866-871.
33. Montine K., Reich E., Olson S. J., Markesbery W. R., Montine T. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer's disease is associated with APOE genotype. J. Neuropathol. Exp. Neurol. 57:1998;415-425.
34. Harlow E., Lane D. Antibodies: A Laboratory Manual. 1988;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
35. Montine T. J., Amarnath V., Martin M. E., Strittmatter W. J., Graham D. G. E-4-Hydroxy-2-nonenal is cytotoxic and crosslinks cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148:1996;89-93.
36. Montine T. J., Montine K. S., Swift L. L. Central nervous system lipoproteins in Alzheimer's disease. Am. J. Pathol. 151:1997;1571-1575.
37. Morrow J. D., Roberts L. J. The isoprostanes: Unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36:1997;1-21.
38. Roberts L. J., Montine T. J., Markesbery W. R. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273:1998;13605-13612.
39. Dickson D., Crystal H. A., Bevona C., Honer W., Vincent I., Davies P. Correlations of synaptic and pathological markers with cognition in the elderly. Neurobiol. Aging. 16:1995;285-304.
40. Schlaf G., Salje C., Wetter A., Stuertz K. K. F., Mader M. Determination of synapsin I and synaptophysin in body fluids by two-site enzyme-linked immunosorbent assays. J. Immunol. Methods. 213:1998;191-199.
41. Schlaf G., Salje C., Poethke R., Felgenhauer K., Mader M. A novel enzyme-linked immunosorbent assay for determination of synaptophysin as compared with other quantitative procedures. J. Neuroimmunol. 67:1996;59-65.
42. Montine T. J., Huang D. Y., Valentine W. M. Crosslinking of apolipoprotein E by products of lipid peroxidation. J. Neuropathol. Exp. Neurol. 55:1996;202-210.
43. Roses A. On the metabolism of apolipoprotein E and the Alzheimer diseases. Exp. Neurol. 132:1995;149-156.
44. Hayek T., Oiknine J., Brook J. G., Aviram M. Increased plasma and lipoprotein lipid peroxidation in apoE-deficient mice. Biochem. Biophys. Res. Commun. 210:1994;1567-1574.
45. Jeong T., Schissel S. L., Tabas I., Pownall H. J., Tall A. R., Jiang X. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects production and catabolic defects and enhances reactivity with mammalian sphinogomyelinase. J. Clin. Invest. 101:1998;905-912.
46. Kuipers F., vanRee J. M., Hofker M. H. Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology. 24:1996;241-247.
47. Maor I., Hayek T., Coleman R., Aviram M. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice. Ateriosclerosis Thrombosis Vascular Biol. 17:1997;2995-2305.
48. Neuzil J., Christison J. K., Iheanacho E. Radical-induced lipoproteins and plasma lipid peroxidation in normal and apolipoprotein E gene knockout (apoE-/-) mice: apoE-/- mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis. J. Lipid Res. 39:1998;354-368.
49. Pratico D., Tangirala, Rader D. J. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nat. Med. 4:1998;1189-1192.
50. Igbavboa U., Avdulov N. A., Chochina S. V., Wood W. G. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in low-density lipoprotein receptor, apolipoprotein E, or both proteins. J. Neurochem. 69:1997;1661-1667.
51. Pettegrew J. W., Klunk W. E., Panchalingam K., McClure R. J., Stanley J. A. Magnetic resonance spectroscopic changes in Alzheimer's disease. Ann. N.Y. Acad. Sci. USA. 826:1997;282-306.
52. Prasad M. R., Yatin M., Dhillon H., Markesbery W. R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23:1998;81-88.
53. Markesbery W. R. Oxidative stress hypothesis in Alzheimer's disease. Free. Rad. Biol. Med. 23:1997;134-147.
54. Montine T. J., Markesbery W. R., Morrow J. D., Roberts L. J. Cerebrospinal fluid F2-isoprostanes are increased in Alzheimer's disease. Ann. Neurol. 44:1998;410-413.